Human Primary Breast Tumor Cells

Product Name	Human Primary Breast Tumor Cells (ER+)
Cat.No	RPC-088
Size	>5*10^5 cells/vial
Description	Human Primary Breast Tumor Cells from Runtogen are isolated from human Breast. The cells are cryopreserved at passage one after purification and delivered frozen. Each vial contains >5 x 10^5 cells in 1 ml volume. This cell product is characterized by immunofluorescence.
Tissue	Breast
Species	Human
Biosafety Level	BSL 1. Runtogen determines the biosafety level of a material based on our risk assessment as guided by the current edition of Biosafety in Microbiological and Biomedical Laboratories (BMBL), U.S. Department of Health and Human Services.
Culture Method	The primary cells must be cultured in a 37 ℃, 5% CO2 incubator.
Quality Control	Human Primary Breast Tumor Cells are negative for mycoplasma, bacteria, yeast, and fungi.
Shipping	Cryopreserved Human Primary Breast Tumor Cells are shipped with dry ice.
Storage	Upon arrival, Check all containers for leakage or breakage. Remove the frozen cells from the dry ice packaging and immediately place the cells at a temperature below -130°C, preferably in liquid nitrogen vapor, until ready for use.
Warranty	Human Primary Breast Tumor Cells are warranted for 30 days from the date of shipment, provided that the customer has stored and handled the product according to the information included on the product datasheet, website, and COA.
Disclaimers	Our cell line product is intended for laboratory research use only. It is not intended for any human or animal therapeutic use, any animal or human consumption, or any diagnostic use. Any proposed commercial use is prohibited without a license from Runtogen.

Human Primary Breast Tumor Cells (ER+)

Online Inquiry

Online Inquiry